Literature DB >> 9069315

Infrastructure for radiotherapy in The Netherlands: development from 1970 to 2010.

W A van Daal1, M A Bos.   

Abstract

In 1993 the radiotherapy advisory committee of the Dutch Health Council published its report on the developments of infrastructure for radiotherapy in The Netherlands during the last 10 years and the prognosis for future needs until 2010. Based on demographic trends, the expected incidence of cancer, the role of radiotherapy in the treatment of cancer, and the workload assessment in a model department, two scenarios are presented for the development of infrastructure. According to the committee, the Quality Scenario would be the most appropriate.

Entities:  

Mesh：

Year:  1997        PMID： 9069315     DOI： 10.1016/s0360-3016(96)00514-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  9 in total

1.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

2.  A Palliative Radiation Oncology Consult Service's Impact on Care of Advanced Cancer Patients.

Authors:  Sanders Chang; Peter May; Nathan E Goldstein; Juan Wisnivesky; Kenneth Rosenzweig; R Sean Morrison; Kavita V Dharmarajan
Journal:  J Palliat Med       Date:  2017-11-30       Impact factor: 2.947

3.  Defining the elements for successful implementation of a small-city radiotherapy department.

Authors:  P S Craighead; P Dunscombe
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

4.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

5.  Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

Authors:  N Tselis; U Maurer; W Popp; H Sack; N Zamboglou
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

6.  A Video Decision Aid Improves Informed Decision Making in Patients With Advanced Cancer Considering Palliative Radiation Therapy.

Authors:  Kavita V Dharmarajan; Chasity B Walters; Tomer T Levin; Carol Ann Milazzo; Christopher Monether; Robin Rawlins-Duell; Roma Tickoo; Daniel E Spratt; Shona Lovie; Gina Giannantoni-Ibelli; Beryl McCormick
Journal:  J Pain Symptom Manage       Date:  2019-08-28       Impact factor: 3.612

7.  Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites.

Authors:  Sonia García Cabezas; Amalia Palacios Eito; María Martínez Paredes; Eleonor Rivin del Campo
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

8.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

9.  Do patients' information needs decrease over the course of radiotherapy?

Authors:  Kirsten F L Douma; Caro C E Koning; Linda C Zandbelt; Hanneke C J M de Haes; Ellen M A Smets
Journal:  Support Care Cancer       Date:  2011-11-13       Impact factor: 3.603
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.